Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment

Background: In patients with differentiated thyroid cancer (DTC) and raising serum thyroglobulin (Tg) after total or near-total thyroidectomy and (131)I remnant ablation an empiric (131)I therapy may be considered. However, outcome data after empiric therapy in did not show a clear evidence of impro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Endocrinol (Lausanne)
Hlavní autoři: Klain, Michele, Pace, Leonardo, Zampella, Emilia, Mannarino, Teresa, Limone, Simona, Mazziotti, Emanuela, De Simini, Giovanni, Cuocolo, Alberto
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Endocrinology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6423899/
https://ncbi.nlm.nih.gov/pubmed/30930852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2019.00146
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky